220 related articles for article (PubMed ID: 29576621)
21. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
Lu C; Shan Z; Li C; Yang L
Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
[TBL] [Abstract][Full Text] [Related]
22. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
23. A novel design of HA-coated nanoparticles co-encapsulating plasmid METase and 5-Fu shows enhanced application in targeting gastric cancer stem cells.
Yang W; Zhang H; Xin L
Biol Chem; 2018 Feb; 399(3):293-303. PubMed ID: 29016350
[TBL] [Abstract][Full Text] [Related]
24. Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Siveen KS; Chinnathambi A; Zayed ME; Alharbi SA; Arfuso F; Kumar AP; Ahn KS; Sethi G
Cancer Lett; 2015 Jul; 363(1):28-36. PubMed ID: 25827070
[TBL] [Abstract][Full Text] [Related]
25. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
Wen L; Cheng F; Zhou Y; Yin C
Saudi J Gastroenterol; 2015; 21(5):313-9. PubMed ID: 26458859
[TBL] [Abstract][Full Text] [Related]
26. APRIL induces cisplatin resistance in gastric cancer cells via activation of the NF-κB pathway.
Zhi X; Tao J; Xiang G; Cao H; Liu Z; Yang K; Lv C; Ni S
Cell Physiol Biochem; 2015; 35(2):571-85. PubMed ID: 25612651
[TBL] [Abstract][Full Text] [Related]
27. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
28. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
30. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Xu GY; Tang XJ
Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
[TBL] [Abstract][Full Text] [Related]
31. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway.
Tang X; Hu G; Xu C; Ouyang K; Fang W; Huang W; Zhang J; Li F; Wang K; Qin X; Li Y
Eur J Pharmacol; 2013 Nov; 720(1-3):84-97. PubMed ID: 24183976
[TBL] [Abstract][Full Text] [Related]
32. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
Lian C; Yang J; Wang X; Xie Y; Xiao Q
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
[TBL] [Abstract][Full Text] [Related]
33. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB.
Du J; Wang Y; Chen D; Ji G; Ma Q; Liao S; Zheng Y; Zhang J; Hou Y
Cancer Lett; 2016 Dec; 383(2):145-153. PubMed ID: 27721019
[TBL] [Abstract][Full Text] [Related]
34. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB.
Han X; Zhang JJ; Han ZQ; Zhang HB; Wang ZA
Cancer Gene Ther; 2018 Dec; 25(11-12):300-308. PubMed ID: 30237418
[TBL] [Abstract][Full Text] [Related]
35. Irigenin sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells.
Xu Y; Gao CC; Pan ZG; Zhou CW
Biochem Biophys Res Commun; 2018 Feb; 496(3):998-1005. PubMed ID: 29305260
[TBL] [Abstract][Full Text] [Related]
36. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
[TBL] [Abstract][Full Text] [Related]
37.
Shao Q; Xu J; Guan X; Zhou B; Wei W; Deng R; Li D; Xu X; Zhu H
Int J Med Sci; 2018; 15(1):86-94. PubMed ID: 29333091
[TBL] [Abstract][Full Text] [Related]
38. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
Chen F; Qin X; Xu G; Gou S; Jin X
Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts.
Zhang HQ; Fang N; Liu XM; Xiong SP; Liao YQ; Jin WJ; Song RF; Wan YY
Asian Pac J Cancer Prev; 2015; 16(9):3907-12. PubMed ID: 25987058
[TBL] [Abstract][Full Text] [Related]
40. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.
Tu SP; Liston P; Cui JT; Lin MC; Jiang XH; Yang Y; Gu Q; Jiang SH; Lum CT; Kung HF; Korneluk RG; Wong BC
Int J Cancer; 2009 Aug; 125(3):688-97. PubMed ID: 19358264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]